Ticker Scorecard - IGMS Basics Company: IGM Biosciences, Inc. IPO Date: September 16, 2019 Sector: Healthcare Industry: Biotech Market Cap: $85.03M Activated in VL: True Average Daily Range Avg Daily Range: $1.42 | 4.42% Avg Daily Range (30 D): $0.15 | 4.31% Avg Daily Range (90 D): $0.55 | 5.32% Institutional Daily Volume Avg Daily Volume: .25M Avg Daily Volume (30 D): .57M Avg Daily Volume (90 D): .34M Trade Size Avg Trade Size (Sh.): 72 Avg Trade Size (Sh.) (30 D): 147 Avg Trade Size (Sh.) (90 D): 106 Institutional Trades Total Inst.Trades: 719 Avg Inst. Trade: $1.57M Avg Inst. Trade (30 D): $1.3M Avg Inst. Trade (90 D): $1.1M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.87M Avg Closing Trade (30 D): $1.42M Avg Closing Trade (90 D): $2.35M Avg Closing Volume: 48.62K     News Jan 9, 2025 @ 6:00 PM IGM Biosciences Provides Strategic Update on Autoi... Source: N/A Nov 4, 2024 @ 12:00 PM IGM Biosciences to Present at Three Upcoming Inves... Source: N/A Sep 18, 2024 @ 3:22 PM Russell 2000 Outpaces S&P 500 As Small Caps Antici... Source: Surbhi Jain Jul 12, 2024 @ 8:25 PM Russell 2000 Index Notches Strongest Week Of Year,... Source: Piero Cingari, Benzinga Staff Writer May 29, 2024 @ 11:00 AM IGM Biosciences to Present at the Jefferies Health... Source: IGM Biosciences, Inc. Financials   TTM Q3 2024 Q2 2024 Basic EPS $-3.61 $-1.01 $-.79 Diluted EPS $-3.61 $-1.01 $-.79 Revenue $ 2.92M $ .52M $ 1.25M Gross Profit $ $ $ Net Income / Loss $ -219.84M $ -61.43M $ -47.9M Operating Income / Loss $ -234.72M $ -64.39M $ -51.36M Cost of Revenue $ $ $ Net Cash Flow $ -132.35M $ -24.2M $ -12.24M PE Ratio